We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Private Equity

Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.

Sign up for a 7-day FREE trial today!

Latest News in Private Equity

  • February 15, 2019

    US, UAE Firms Net EU Approval To Reel In Greek Fish Farms

    Manhattan-based Amerra Capital Management and an Abu Dhabi-based investment firm won European Commission approval to take control of three Greek aquaculture companies on Friday, provided they offload some of the Mediterranean fish farms and small fish hatcheries.

  • February 15, 2019

    Deals Rumor Mill: Radian, Thomas Cook, TSE

    Radian Group Inc. reportedly held unsuccessful deal talks, Thomas Cook Group PLC is mulling a sale of its airline unit, and Tokyo Commodity Exchange and the owner of the Tokyo Stock Exchange have agreed to merge.

  • February 15, 2019

    Taxation With Representation: Kirkland, McAfee, Latham

    In this week’s Taxation with Representation, Ingersoll Rand Co. lobs a $1.45 billion offer for Precision Flow Systems, Morgan Stanley takes over Solium Capital Inc. in a $900 million deal, and Toro Co. buys The Charles Machine Works Inc. for $700 million.

  • February 15, 2019

    UK Litigation Roundup: Here's What You Missed In London

    The last week has seen the European arm of a Japanese investment bank sue a Saudi billionaire, the former prime minister of Qatar face action involving a pricey mansion and a Swiss bank file claims against executives of a defunct business group being investigated by the U.K.'s fraud watchdog. Here, Law360 looks at those and other new claims in the U.K.

  • February 15, 2019

    WilmerHale-Led Stealth Biotherapeutics Debuts With $78M IPO

    Venture capital-backed Stealth BioTherapeutics Inc. made its debut on the market Friday, one day after picking up $78 million in an initial public offering priced at the low end of the WilmerHale-led biotechnology company’s range.

See more Private Equity news

Private Equity

Areas of Coverage

  • Private equity deals valued at $50MM or more
  • Venture capital investments of $25MM or more
  • Mergers and acquisitions
  • Capital investments, including mezzanine and growth capital deals
  • Joint ventures involving private equity firms
  • Hostile takeovers and leveraged buyouts
  • Distressed investment deals
  • U.S. Commodity Futures Trading Commission
  • Federal Trade Commission
  • Financial Industry Regulatory Authority
  • Public Company Accounting Oversight Board
  • U.S. Department of Justice
  • U.S. Department of the Treasury
  • U.S. Securities and Exchange Commission
  • International competition and securities regulators
  • Dodd-Frank Act
  • Delaware corporate law
  • Antitrust and consumer protection controls
  • Private equity industry lobbying
  • International banking legislation and regulation
  • Merger reviews
  • Second requests
  • Challenges and divestitures
  • Litigation
  • Antitrust suits
  • Shareholder disputes
  • Corporate governance fights
  • Poison pill challenges
  • Hostile takeover disputes
  • Privacy and consumer protection suits
  • Bankruptcy proceedings involving private equity stakeholders
  • Personnel moves
  • Profiles of private equity practices


  • Private equity lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the private equity industry
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals